Selection dramatically reduces effective population size in HIV-1 infection

被引:18
|
作者
Liu, Yi [1 ]
Mittler, John E. [1 ]
机构
[1] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA
关键词
D O I
10.1186/1471-2148-8-133
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: In HIV-1 evolution, a 100-100,000 fold discrepancy between census size and effective population size (N(e)) has been noted. Although it is well known that selection can reduce N(e), high in vivo mutation and recombination rates complicate attempts to quantify the effects of selection on HIV-1 effective size. Results: We use the inbreeding coefficient and the variance in allele frequency at a linked neutral locus to estimate the reduction in N(e) due to selection in the presence of mutation and recombination. With biologically realistic mutation rates, the reduction in Ne due to selection is determined by the strength of selection, i. e., the stronger the selection, the greater the reduction. However, the dependence of Ne on selection can break down if recombination rates are very high ( e. g., r >= 0.1). With biologically likely recombination rates, our model suggests that recurrent selective sweeps similar to those observed in vivo can reduce within-host HIV-1 effective population sizes by a factor of 300 or more. Conclusion: Although other factors, such as unequal viral reproduction rates and limited migration between tissue compartments contribute to reductions in Ne, our model suggests that recurrent selection plays a significant role in reducing HIV-1 effective population sizes in vivo.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Molecular epidemiology of HIV-1 infection in immigrant population in northern Italy
    Sagnelli, Caterina
    Uberti-Foppa, Caterina
    Bagaglio, Sabrina
    Cella, Eleonora
    Scolamacchia, Vittoria
    Hasson, Hamid
    Salpietro, Stefania
    Messina, Emanuela
    Morsica, Giulia
    Angeletti, Silvia
    Ciccozzi, Massimo
    Lazzarin, Adriano
    Sagnelli, Evangelista
    EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [42] HIV-1 infection in China
    Neild, PJ
    Gazzard, BG
    LANCET, 1997, 350 (9082): : 963 - 963
  • [43] Pediatric HIV-1 infection
    Melvin, AJ
    Frenkel, LM
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1997, 24 (04) : 911 - &
  • [44] Immunophilins and HIV-1 infection
    Minder, D
    Böni, J
    Schüpbach, J
    Gehring, H
    ARCHIVES OF VIROLOGY, 2002, 147 (08) : 1531 - 1542
  • [45] Paediatric HIV-1 infection
    Burns, DN
    Mofenson, LM
    LANCET, 1999, 354 : S1 - S6
  • [46] Apoptosis in HIV-1 infection
    Bell, DJ
    Dockrell, DH
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2003, 17 (02) : 178 - 183
  • [47] THERAPY OF HIV-1 INFECTION
    KOZAL, MJ
    MERIGAN, TC
    CURRENT OPINION IN INFECTIOUS DISEASES, 1994, 7 (01) : 72 - 81
  • [48] Pathogenesis of HIV-1 Infection
    Ozbal, Yusuf
    ERCIYES MEDICAL JOURNAL, 2007, 29 (03) : 228 - 234
  • [49] HIV-1 and tuberculosis infection
    Warren, RM
    van Helden, PD
    LANCET, 2002, 359 (9317): : 1618 - 1619
  • [50] Immunopathogenesis of HIV-1 infection
    Cao, H
    Walker, BD
    CLINICS IN DERMATOLOGY, 2000, 18 (04) : 401 - 410